The auto industry publicly asked the Trump administration not to rush into certifying readiness for the U.S.-Mexico-Canada Agreement's entry into force, given the fact that “a global pandemic is significantly disrupting our supply chains, and the industry is throwing all available resources into managing production through this crisis for our employees and for the broader U.S. economy.”
Canada's House of Commons approved the U.S.-Mexico-Canada Agreement -- called CUSMA in Canada -- by unanimous consent March 13, before adjourning until April 20 due to the coronavirus pandemic. The Canadian Senate passed it less than an hour later. Royal Assent, the equivalent of a presidential signature in the U.S., followed shortly, and the Senate adjourned as well. Now, all three countries must continue to work on uniform regulations so that they can certify the treaty is ready to enter into force. Efforts to slow the spread of the coronavirus disease COVID-19 may slow that process, because the countries also have to evaluate the progress toward fulfilling commitments, such as setting up labor courts in Mexico and getting new rules of origin processes in place. Once that certification is issued, NAFTA will be replaced on the first day of the third month after the announcement.
An update to the Congressional Research Service's report on rules of origin notes that some in the trade community believe that more restrictive rules of origin, such as those that will be part of the NAFTA rewrite for autos, raise compliance costs for traders and may lead companies to avoid using the free trade agreement because the rules are so onerous. Because of those critiques, Congress may want to consider that in future FTAs, the report said.
International Trade Today is providing readers with some of the top stories for Feb. 18-21 in case they were missed.
The Canadian Parliament is moving the successor to NAFTA along, so that a March ratification vote is still looking likely, news from Canada says. While the U.S.-Mexico-Canada Agreement will be reviewed by the agriculture, natural resources and industry/science/technology committees, not just the trade committee, the other committees only have until Feb. 25 for that review, a report from ipolitics said.
The effort to give Congress more say on Section 232 tariffs that has stalled so far is not broad enough to ensure that erratic tariffs are not levied, according to experts who spoke during a Feb. 5 briefing held by Rep. Stephanie Murphy, D-Fla., a Ways and Means Committee member who has hosted trade sessions three times in the last few months. No other members of the committee responsible for trade attended, but Rep. Jim Cooper, Rep. Donna Shalala and Rep. Jim Costa, all Democrats, listened for at least part of the session, in addition to many Hill staffers and some lawyers, diplomats and industry representatives.
International Trade Today is providing readers with some of the top stories for Jan. 27-31 in case they were missed.
The many complicated “provisions” for implementing the U.S.-Mexico-Canada Agreement on free trade plausibly means July 1 is the “absolute earliest” date it can “enter into force,” Nicole Bivens Collinson, international trade expert with Sandler, Travis, told a Sports & Fitness Industry Association webinar Jan. 29. President Donald Trump signed USMCA’s enabling legislation into law on Jan. 29 (see 2001290035), saying the agreement “contains critical protections for intellectual property, including trade secrets, digital services and financial services.”
President Donald Trump, in a signing ceremony Jan. 29, said he would be ending the devastation that NAFTA brought and said that its replacement will strengthen what he called the country's blue-collar boom, “delivering massive gains for the loyal citizens of our nation.” Democrats, who were not invited to the White House ceremony, during their own press conferences ahead of the signing, emphasized how much they'd changed what the president submitted to them, by strengthening labor enforcement and environmental provisions, and removing patent protections for certain kinds of prescription drugs.
Outside the most complicated issues to be implemented as part of the U.S.-Mexico-Canada Agreement, such as rules of origin, CBP also sees new “opportunities that are touched on in the agreement,” said Brenda Smith, executive assistant commissioner of CBP’s Office of Trade, during a Jan. 29 interview. “For example, there's some guidance around establishing single windows, there are opportunities for us to validate through site visits compliance with all customs laws and that's a much broader scope than it was before,” she said. President Donald Trump signed the implementing bill into law the same day, though Canada still must give its final approval, and implementing actions must be completed by all countries before USMCA can take effect.